Safety/Efficacy of Intravenous Zoledronic Acid When Added to Standard Therapies in Patients With Breast Cancer and Metastatic Bone Lesions
Status: TERMINATED
Study type: INTERVENTIONAL
Conditions: Breast Cancer With Bone Metastasis
Interventions: DRUG: Zoledronic acid
Sponsor: Novartis